Trametes versicolor 52J


Credit: Geneviève Quenneville

Genome Project

— Genozymes Project, Concordia University

EST Project

cDNA annotation — Centre for Structural and Functional Genomics, Concordia University

Species Information (from MycoBank)

Current name

Trametes versicolor (L.) Lloyd 1920 [1]

Basionym

Boletus versicolor L. 1753

Obligate synonym

Boletus suberosus Batsch 1783
Poria versicolor (Linnaeus) Scopoli 1772
Agaricus versicolor (Linnaeus) Lamarck 1783
Agarico-suber versicolor (Linnaeus) Paulet
Sistotrema versicolor (Linnaeus) Trattinnick 1804
Polyporus versicolor (Linnaeus) Fries 1821
Polystictus versicolor (Linnaeus) Fries 1851
Hansenia versicolor (Linnaeus) P. Karsten 1879
Bjerkandera versicolor (Linnaeus) P. Karsten 1881
Coriolus versicolor (Linnaeus) Quélet 1886
Microporus versicolor (Linnaeus) Kuntze 1898

Morphic status

Teleomorph (anamorph unknown)

Lineage (abbreviated from MycoBank)

Fungi; Basidiomycota; Agaricomycetes; Polyporales; Polyporaceae; Trametes

Ecology

Trametes versicolor, a white-rot basidiomycete, grows on tree trunks and can be found all over the world in many different climates [2,3].

Interesting Features

Decomposer of lignocellulose

One of the most competent wood-degrading white-rot fungi, Trametes versicolor causes the simultaneous degradation of lignin, cellulose, and hemicelluloses[4,5]. This basidiomycete fungus also has a degradation capacity of polycyclic aromatic hydrocarbons and organic and synthetic dyes [4-7].

Under lignocellulose-degrading conditions Trametes versicolor produces and secretes cellobiose dehydrogenase [8], laccase [9], manganese peroxidise [9], lignin peroxidise [10,11], and can bleach hardwood kraft pulp [12]. The identification of new enzymes related to biomass degradation in this fungus could improve the current technology for bioproducts production.

Bioactive Molecules

Trametes versicolor, one of the most researched medicinal mushrooms, has a long history of use in Asia as medicine. Two polysaccharide constituents of Trametes versicolor, Krestin (PSK) and polysaccharide peptide (PSP), have been related to anticancer activity [2. 13-15].

References

1. Lloyd CG, Mycological Notes 65. Mycological Writings, 1921. 6: 1029-1101.


2. Standish LJ, et al. (2008) Trametes versicolor mushroom immune therapy in breast cancer. J Soc Integr Oncol 6: 122-8.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845472/?tool=pubmed


3. Garmaroody ER et al. (2011) The effects of fungi pre-treatment of poplar chips on the kraft fiber properties. Bioresour Technol 102: 4165-4170.

http://www.ncbi.nlm.nih.gov/pubmed/21232938


4. Tanaka H, Itakura S and Enoki A, (1999) Hydroxyl radical generation by an extracellular low-molecular-weight substance and phenol oxidase activity during wood degradation by the white-rot basidiomycete Trametes versicolor. Journal of Biotechnology 36: 57-70

http://www.ncbi.nlm.nih.gov/pubmed/10704993


5. Collin PJ and Dobson A, (1997) Regulation of Laccase Gene Transcription in Trametes versicolor. Appl Environ Microbiol. 63 : 3444-50.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1389241/pdf/hw3444.pdf


6. Xavier, AMRB, et al., (2007) Trametes versicolor growth and laccase induction with by-products of pulp and paper industry. Electronic Journal of Biotechnology 10: 443-451.

http://www.ejbiotechnology.info/content/vol10/issue3/full/1/index.html (link not working - site down? June 20, 2011)

7. Novotný C et al. (2004) Ligninolytic fungi in bioremediation: extracellular enzyme production and degradation rate. Soil Biology and Biochemistry 36: 1545-1551.

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TC7-4D0GP6C-1&_user=1069146&_coverDate=10%2F01%2F2004&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_searchStrId=1689253661&_rerunOrigin=google&_acct=C000051262&_version=1&_urlVersion=0&_userid=1069146&md5=b6ffcff511408721a8184faa218c9387&searchtype=a


8. Dumonceaux TJ et al (1998) Cloning and sequencing of a gene encoding cellobiose dehydrogenase from Trametes versicolor. Gene 210: 211-219.

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T39-3SRBHWR-1B&_user=1069146&_coverDate=04%2F14%2F1998&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_searchStrId=1689255442&_rerunOrigin=google&_acct=C000051262&_version=1&_urlVersion=0&_userid=1069146&md5=59da00e4dbcaadf5b4b29e9b0b058528&searchtype=a


9. Paice, MG et al. (1993) Manganese Peroxidase, Produced by Trametes versicolor during Pulp Bleaching, Demethylates and Delignifies Kraft Pulp. Appl Environ Microbiol 59: 260-265.

http://aem.asm.org/cgi/reprint/59/1/260.pdf


10. Dodson PJ et al. (1987) Production and properties of an extracellular peroxidase from Coriolus versicolor which catalyses Cα-Cβ cleavage in a lignin model compound. FEMS Microbiology Letters 42: 17-22

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T2W-47DKM39-15&_user=1069146&_coverDate=06%2F30%2F1987&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_searchStrId=1689255910&_rerunOrigin=google&_acct=C000051262&_version=1&_urlVersion=0&_userid=1069146&md5=b1f93d283b935bc1dff9fa7aa70c353b&searchtype=a


11. Johansson T, Nyman PO, and Cullen D (2002) Differential Regulation of mnp2, a New Manganese Peroxidase-Encoding Gene from the Ligninolytic Fungus Trametes versicolor PRL 572. Appl Environ Microbiol. 68: 2077—2080.

http://www.ncbi.nlm.nih.gov/pubmed/11916737


12. Addleman K and Archibald F (1993) Kraft Pulp Bleaching and Delignification by Dikaryons and Monokaryons of Trametes versicolor. Appl Environ Microbiol 59: 266-273.

http://aem.asm.org/cgi/reprint/59/1/266.pdf


13. Kidd PM, (2000) The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5: 4-27.

http://www.ncbi.nlm.nih.gov/pubmed/10696116


14. Nio Y et al. (1992) Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer. Biotherapy 4:117-128.

http://www.springerlink.com/content/ln153380hw242412/


15. Toi M et al. (1992) Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization. Cancer 70: 2475-83.

http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19921115)70:10%3C2475::AID-CNCR2820701014%3E3.0.CO;2-P/abstract